belle glp-1 My Journey with A science We are BellMD! π€― Literally
Description
Ozempic and Mounjaro are still both technically only FDA-approved for the treatment of type 2 diabetes, but many physicians will safely prescribe them off-label for weight loss
Once-Monthly Maridebart Cafraglutide for Obesity Treatment: UK Guide Once-monthly maridebart cafraglutide (AMG 133) is an investigational obesity treatment combining a GLP-1 receptor agonist with a GIP receptor antagonist in a single monthly injection
Individuals sensitive to caffeine or adhesives should proceed cautiously and consult their healthcare provider if uncertain
said at Thursdays announcement
